Table 2.
Multiple-Moderator Multivariate Analyses (k=41; total ESs = 61)
y | 95% CI | p | |
---|---|---|---|
Percentage Days Abstinent | |||
Intercept | 0.197 | [0.070, 0.316] | <.003* |
Publication Year | −0.028 | [−0.052, −0.003] | .027* |
Multi-Center Design | −0.090 | [−0.249, 0.069] | .270 |
Placebo Run-In | −0.061 | [−0.299, 0.177] | .615 |
Pub Year X Multi-Center | 0.040 | [−0.012, 0.091] | .131 |
Relapse to Heavy Drinking | |||
Intercept | 0.304 | [0.166, 0.441] | <.001* |
Publication Year | −0.054 | [−0.081, −0.026] | .001* |
Multi-Center Design | −0.124 | [−0.303, 0.055] | .180 |
Placebo Run-In | −0.280 | [−0.589, 0.033] | .079 |
Pub Year X Multi-Center | 0.050 | [−0.011, 0.102] | .120 |
Note. Overall tests of model significance were Q(31) =36.98, p = .178; Publication year was grand mean centered. Multi-Center Design is coded dichotomously where 1 = multi-site and 0 = single-site. Placebo Run-In was coded dichotomously where 0 = No Run-In and 1 = Yes. Multivariate analyses used a mixed model (studies random, levels of moderator variables fixed);
p-value < 0.05.